BPA - AB QuantStudio 5 (ABI 7500 replace)
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $7,000,000 to $13,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Points of contact
-
- HFP Acquisition Liaison hfpacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is forecasting a Blanket Purchase Agreement (BPA) for QuantStudio 5 analytical laboratory instruments to replace existing ABI 7500 PCR systems across seven microbiology laboratories. These instruments serve as primary tools for DNA and RNA screening detection, with the replacement driven by the vendor's discontinuation of service and manufacturing support for the legacy systems. The solicitation is estimated to be released on December 1, 2025, with an anticipated award date of June 1, 2026.
The contract value is estimated between $7 million and $13 million, with the requirement encompassing base units plus four option years across all seven laboratories. Inquiries regarding this procurement opportunity should be directed to the FDA's Acquisition Liaison at hfpacquisitions@fda.hhs.gov. This requirement falls under NAICS code 334516 for Analytical Laboratory Instrument Manufacturing and represents a non-set-aside procurement open to all eligible vendors.
Forecast text
BPA - AB QuantStudio 5 (ABI 7500 replace)
Base + 4 OY
Units are required in all 7 microbiology laboratories to replace existing ABI 7500 PCR systems since the vendor will be discontinuing their service and manufacture. These are the primary instruments for DNA and RNA screening detection in the labs.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast